Where do we go from here? Confirmation of bad news that the market was pricing in. If the coronavirus worsens then expect more delays ect. Only thing saving them at this point is either confirmation of a new project or hitting bigger Q1 numbers. But with production not ready till mid 2020 it will be second half weighted. If they keep missing targets maybe they should think about being more conservative in their forecasts and try exceeding them. I'm not saying making a forecast in this type of business is easy, but think about the perception they have created. Nothing worse than constantly missing targets and blaming external factors. Also, were the cash receipts lower than expected?
- Forums
- ASX - By Stock
- PET
- Ann: Business Update
Ann: Business Update, page-17
-
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PET (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.60M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
PET (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online